Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 26

1.

GP38-targeting monoclonal antibodies protect adult mice against lethal Crimean-Congo hemorrhagic fever virus infection.

Golden JW, Shoemaker CJ, Lindquist ME, Zeng X, Daye SP, Williams JA, Liu J, Coffin KM, Olschner S, Flusin O, Altamura LA, Kuehl KA, Fitzpatrick CJ, Schmaljohn CS, Garrison AR.

Sci Adv. 2019 Jul 10;5(7):eaaw9535. doi: 10.1126/sciadv.aaw9535. eCollection 2019 Jul.

2.

Animal Models for Crimean-Congo Hemorrhagic Fever Human Disease.

Garrison AR, Smith DR, Golden JW.

Viruses. 2019 Jun 28;11(7). pii: E590. doi: 10.3390/v11070590. Review.

3.

Exploring Crimean-Congo Hemorrhagic Fever Virus-Induced Hepatic Injury Using Antibody-Mediated Type I Interferon Blockade in Mice.

Lindquist ME, Zeng X, Altamura LA, Daye SP, Delp KL, Blancett C, Coffin KM, Koehler JW, Coyne S, Shoemaker CJ, Garrison AR, Golden JW.

J Virol. 2018 Oct 12;92(21). pii: e01083-18. doi: 10.1128/JVI.01083-18. Print 2018 Nov 1.

4.

African and Asian Zika Virus Isolates Display Phenotypic Differences Both In Vitro and In Vivo.

Smith DR, Sprague TR, Hollidge BS, Valdez SM, Padilla SL, Bellanca SA, Golden JW, Coyne SR, Kulesh DA, Miller LJ, Haddow AD, Koehler JW, Gromowski GD, Jarman RG, Alera MTP, Yoon IK, Buathong R, Lowen RG, Kane CD, Minogue TD, Bavari S, Tesh RB, Weaver SC, Linthicum KJ, Pitt ML, Nasar F.

Am J Trop Med Hyg. 2018 Feb;98(2):432-444. doi: 10.4269/ajtmh.17-0685. Epub 2017 Dec 21.

5.

A DNA vaccine for Crimean-Congo hemorrhagic fever protects against disease and death in two lethal mouse models.

Garrison AR, Shoemaker CJ, Golden JW, Fitzpatrick CJ, Suschak JJ, Richards MJ, Badger CV, Six CM, Martin JD, Hannaman D, Zivcec M, Bergeron E, Koehler JW, Schmaljohn CS.

PLoS Negl Trop Dis. 2017 Sep 18;11(9):e0005908. doi: 10.1371/journal.pntd.0005908. eCollection 2017 Sep.

6.

[18F]DPA-714 PET Imaging Reveals Global Neuroinflammation in Zika Virus-Infected Mice.

Kuszpit K, Hollidge BS, Zeng X, Stafford RG, Daye S, Zhang X, Basuli F, Golden JW, Swenson RE, Smith DR, Bocan TM.

Mol Imaging Biol. 2018 Apr;20(2):275-283. doi: 10.1007/s11307-017-1118-2.

7.

Human polyclonal antibodies produced in transchromosomal cattle prevent lethal Zika virus infection and testicular atrophy in mice.

Stein DR, Golden JW, Griffin BD, Warner BM, Ranadheera C, Scharikow L, Sloan A, Frost KL, Kobasa D, Booth SA, Josleyn M, Ballantyne J, Sullivan E, Jiao JA, Wu H, Wang Z, Hooper JW, Safronetz D.

Antiviral Res. 2017 Oct;146:164-173. doi: 10.1016/j.antiviral.2017.09.005. Epub 2017 Sep 8.

PMID:
28893603
8.

An attenuated Machupo virus with a disrupted L-segment intergenic region protects guinea pigs against lethal Guanarito virus infection.

Golden JW, Beitzel B, Ladner JT, Mucker EM, Kwilas SA, Palacios G, Hooper JW.

Sci Rep. 2017 Jul 5;7(1):4679. doi: 10.1038/s41598-017-04889-x.

9.

Neuropathogenesis of Zika Virus in a Highly Susceptible Immunocompetent Mouse Model after Antibody Blockade of Type I Interferon.

Smith DR, Hollidge B, Daye S, Zeng X, Blancett C, Kuszpit K, Bocan T, Koehler JW, Coyne S, Minogue T, Kenny T, Chi X, Yim S, Miller L, Schmaljohn C, Bavari S, Golden JW.

PLoS Negl Trop Dis. 2017 Jan 9;11(1):e0005296. doi: 10.1371/journal.pntd.0005296. eCollection 2017 Jan.

10.

Glycoprotein-Specific Antibodies Produced by DNA Vaccination Protect Guinea Pigs from Lethal Argentine and Venezuelan Hemorrhagic Fever.

Golden JW, Maes P, Kwilas SA, Ballantyne J, Hooper JW.

J Virol. 2016 Jan 20;90(7):3515-29. doi: 10.1128/JVI.02969-15.

11.

Corrigendum to "Animal Models for the Study of Rodent-Borne Hemorrhagic Fever Viruses: Arenaviruses and Hantaviruses".

Golden JW, Hammerbeck CD, Mucker EM, Brocato RL.

Biomed Res Int. 2015;2015:313190. doi: 10.1155/2015/313190. Epub 2015 Oct 26. No abstract available.

12.

Animal Models for the Study of Rodent-Borne Hemorrhagic Fever Viruses: Arenaviruses and Hantaviruses.

Golden JW, Hammerbeck CD, Mucker EM, Brocato RL.

Biomed Res Int. 2015;2015:793257. doi: 10.1155/2015/793257. Epub 2015 Jul 21. Review. Erratum in: Biomed Res Int. 2015;2015:313190.

13.

Side-by-side comparison of gene-based smallpox vaccine with MVA in nonhuman primates.

Golden JW, Josleyn M, Mucker EM, Hung CF, Loudon PT, Wu TC, Hooper JW.

PLoS One. 2012;7(7):e42353. doi: 10.1371/journal.pone.0042353. Epub 2012 Jul 31.

14.

Impact of host proteases on reovirus infection in the respiratory tract.

Nygaard RM, Golden JW, Schiff LA.

J Virol. 2012 Jan;86(2):1238-43. doi: 10.1128/JVI.06429-11. Epub 2011 Nov 9.

15.

Polyclonal antibody cocktails generated using DNA vaccine technology protect in murine models of orthopoxvirus disease.

Golden JW, Zaitseva M, Kapnick S, Fisher RW, Mikolajczyk MG, Ballantyne J, Golding H, Hooper JW.

Virol J. 2011 Sep 20;8:441. doi: 10.1186/1743-422X-8-441.

16.

The strategic use of novel smallpox vaccines in the post-eradication world.

Golden JW, Hooper JW.

Expert Rev Vaccines. 2011 Jul;10(7):1021-35. doi: 10.1586/erv.11.46. Review.

PMID:
21806397
17.

Evaluating the orthopoxvirus type I interferon-binding molecule as a vaccine target in the vaccinia virus intranasal murine challenge model.

Golden JW, Hooper JW.

Clin Vaccine Immunol. 2010 Nov;17(11):1656-65. doi: 10.1128/CVI.00235-10. Epub 2010 Sep 15.

18.

Molecular smallpox vaccine delivered by alphavirus replicons elicits protective immunity in mice and non-human primates.

Hooper JW, Ferro AM, Golden JW, Silvera P, Dudek J, Alterson K, Custer M, Rivers B, Morris J, Owens G, Smith JF, Kamrud KI.

Vaccine. 2009 Dec 11;28(2):494-511. doi: 10.1016/j.vaccine.2009.09.133. Epub 2009 Oct 13.

19.

Targeting the vaccinia virus L1 protein to the cell surface enhances production of neutralizing antibodies.

Golden JW, Josleyn MD, Hooper JW.

Vaccine. 2008 Jun 25;26(27-28):3507-15. doi: 10.1016/j.vaccine.2008.04.017. Epub 2008 Apr 28.

PMID:
18485547
20.

Heterogeneity in the A33 protein impacts the cross-protective efficacy of a candidate smallpox DNA vaccine.

Golden JW, Hooper JW.

Virology. 2008 Jul 20;377(1):19-29. doi: 10.1016/j.virol.2008.04.003. Epub 2008 May 14.

Supplemental Content

Loading ...
Support Center